Wei Guo

Wei Guo


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2026 in Cellular & Molecular Biology Letters
Verified
Journal Article
Open access
PDF file
SZShuai Zhang
Shuai Zhang
LWLinping Wang
Linping Wang
BZBingjie Zhao
Bingjie Zhao
TDTengteng Dai
Tengteng Dai
MNMaolin Nie
Maolin Nie
DDDongshu Du
Dongshu Du
Preeclampsia (PE) is a pregnancy-specific disorder rooted in placental dysfunction, characterized by new-onset hypertension with proteinuria and/or end-org

3 September 2026 in Clinical and Experimental Hypertension
Verified
Journal Article
Open access
HLHaisheng Liu
Haisheng Liu
XCXiaole Chang
Xiaole Chang
LWLinping Wang
Linping Wang
WLWen Lu
Wen Lu
CYChen Yu
Chen Yu
WGWei Guo
Wei Guo
1. Hypertension remains a critical global public health challenge. As reported in the WHO Global Hypertension Report 2023, approximately 1.3 billion people worldwide were living with hypertension i...

Verified
Journal Article
Open access
PDF file
YCYue Chen Chen
Yue Chen Chen
WGWei Guo
Wei Guo
JWJichun Wang
Jichun Wang
MWMin Wang
Min Wang
YYYuying Yang
Yuying Yang
Renjun WangRenjun Wang
Renjun Wang
Mechanosensitive Piezo1 channels participate in regulating pain sensitivity, insulin secretion, and vascular tension; however, their expression in the autonomic paraventricular nucleus (PVN) and role in modulating sympathetic outflow and cardiovascular function remain unstudied. In this study, unilateral PVN microinjection of the Piezo1 channel blocker Dooku1 (0.1, 1, 10, 100, and 200 pmol) administered to anesthetized male rats increased renal sympathetic nerve activity (RSNA) and mean artery pressure (MAP) in a dose-dependent manner, with maximum increases of 93 ± 30% (p < 0.0001) and 21 ± 5 mmHg (p < 0.0001), respectively, elicited by Dooku1 at 100 pmol. Similarly, PVN microinjection of the peptide Piezo1 channel blocker GsMTx4 (1 nmol) significantly increased RSNA (p < 0.001) and MAP (p < 0.0001). Conversely, PVN-microinjected Piezo1 channel activators Yoda1 (5 nmol) and Jedi2 (5 nmol) did not significantly alter RSNA or MAP. Western blot and qRT-PCR analyses of the hypothalamic PVN showed abundant Piezo1 mRNA and protein expression. Immunofluorescence detection showed that Piezo1 was expressed in pre-sympathetic PVN neurons with axons projecting to the rostral ventrolateral medulla. We conclude that Piezo1 channels expressed in the autonomic PVN neurons play an important role in regulating sympathetic outflow and cardiovascular function.